Journals / JAREM / 2022 / Cilt: 12 - Sayı: 1

Evaluation of the Relationship Between Thrombolytic Treatment Complications and Laboratory Parameters in Acute Ischemic Stroke Patients

Akut İskemik İnmeli Hastalarda Trombolitik Tedavi Komplikasyonları ileLaboratuvar Parametreleri Arasındaki İlişkinin Değerlendirilmesi

Journal
JAREM
Pages
36–41
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

NIHSS score at admission, NIHSS score at discharge, and mRS score were significantly higher in the group that developed complications after treatment (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to investigate the role of serum uric acid and lactate levels and mean platelet volume in predicting treatment success in patients with ischemic stroke.
📊
Key Findings & Data:Results: Of all patients, 58.1% of the were male.
💡
Conclusion & Impact:NIHSS score at admission, NIHSS score at discharge, and mRS score were significantly higher in the group that developed complications after treatment (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed to investigate the role of serum uric acid and lactate levels and mean platelet volume in predicting treatment success in patients with ischemic stroke. Methods: One hundred and five patients who were diagnosed with cerebrovascular disease and received thrombolytic or thrombectomy treatment were included in the study. Patients were divided into two groups as patients who developed complications and who did not develop complications. Demographical characteristics, laboratory findings, the National Institutes of Health Stroke Scale (NIHSS) scores at admission and at discharge, and Modified Rankin Scale (mRS) score were investigated retrospectively. Results: Of all patients, 58.1% of the were male. There were no differences in terms of laboratory parameters between the groups. NIHSS score at admission, NIHSS score at discharge, and mRS score were significantly higher in the group that developed complications after treatment (p

Özet

Amaç: İskemik inmeli hastalarda tedavi başarısını öngörmede serum ürik asit ve laktat düzeyleri ile ortalama trombosit hacminin rolünü araştırmayı amaçladık. Yöntemler: Çalışmaya serebrovasküler hastalık tanısı konan ve trombolitik veya trombektomi tedavisi alan 115 hasta dahil edildi. Hastalar komplikasyon gelişen ve gelişmeyen olarak iki gruba ayrıldı. Demografik özellikler, laboratuvar bulguları, Ulusal Sağlık Enstitüleri İnme Ölçeği (NIHSS) kabul ve taburculuk skoru ve Modifiye Rankin Ölçeği (mRS) skoru geriye dönük olarak incelendi. Bulgular: Tüm hastaların %58,1’i erkekti. Gruplar arasında laboratuvar parametrelerinde fark yoktu. Başvuruda NIHSS skoru, taburculukta NIHSS skoru ve mRS skoru, tedavi sonrası komplikasyon gelişen grupta anlamlı olarak daha yüksekti (p

🔖

Cite This Article

ÇALIK, M., ÖZTÜRK, D. (2022). Evaluation of the Relationship Between Thrombolytic Treatment Complications and Laboratory Parameters in Acute Ischemic Stroke Patients. JAREM, Cilt: 12 - Sayı: 1, 36–41. https://ajindex.com/articles/558142

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Goyal M, Ospel JM, Kappelhof M, Ganesh A. Challenges of Outcome Prediction for Acute Stroke Treatment Decisions. Stroke 2021; 52: 1921-8
  2. Katan M, Luft A. Global Burden of Stroke. Semin Neurol 2018; 38: 208-11
  3. Slawski D, Heit JJ. Treatment Challenges in Acute Minor Ischemic Stroke. Front Neurol. 2021; 12: 723637
  4. Ma M, Wang L, Huang W, Zhong X, Li L, Wang H, et al. Meta-analysis of the correlation between serum uric acid level and carotid intima-media thickness. PLoS One 2021; 16: e0246416
  5. Rahimi-Sakak F, Maroofi M, Rahmani J, Bellissimo N, Hekmatdoost A. Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants. BMC Cardiovasc Disord 2019; 19: 218
  6. Soltani Z, Rasheed K, Kapusta DR, Reisin E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep 2013; 15: 175-81
  7. Hjortnaes J, Algra A, Olijhoek J, Huisman M, Jacobs J, van der Graaf Y, et al. Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome. J Rheumatol 2007; 34: 1882-7
  8. Mapoure YN, Ayeah CM, Doualla MS, Ba H, Ngahane HBM, Mbahe S, et al. Serum Uric Acid Is Associated with Poor Outcome in Black Africans in the Acute Phase of Stroke. Stroke Res Treat 2017; 2017: 1935136
  9. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 1981; 78: 6858-62
  10. Fabbrini E, Serafini M, Colic Baric I, Hazen SL, Klein S. Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes 2014; 63: 976-81
  11. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009; 61: 225- 32
  12. Meregalli A, Oliveira RP, Friedman G. Occult hypoperfusion is associated with increased mortality in hemodynamically stable, high-risk, surgical patients. Crit Care 2004; 8: R60-5
  13. Kushimoto S, Akaishi S, Sato T, Nomura R, Fujita M, Kudo D, et al. Lactate, a useful marker for disease mortality and severity but an unreliable marker of tissue hypoxia/hypoperfusion in critically ill patients. Acute Med Surg 2016; 3: 293-7
  14. Bakker J, Nijsten MW, Jan